Evaluating the Role of Methylated Circulating Tumor DNA in Combination With Pathological Prognostic Factors for Predicting Recurrence of Colorectal Cancer.
Autorzy:
Al Naji H; Department of Medicine, College of Medicine and Public Health, Flinders University, Bedford Park, SA, Australia. Winter JM; Cancer Research, Flinders Health and Medical Research Institute, Flinders University, Bedford Park, SA, Australia. Pedersen SK; Clinical Genomics Pty Ltd, North Ryde, NSW, Australia. Roy A; Cancer Research, Flinders Health and Medical Research Institute, Flinders University, Bedford Park, SA, Australia.; Department of Oncology, Flinders Medical Centre, SALHN, Bedford Park, SA, Australia. Byrne SE; Cancer Research, Flinders Health and Medical Research Institute, Flinders University, Bedford Park, SA, Australia. YoungGP; Cancer Research, Flinders Health and Medical Research Institute, Flinders University, Bedford Park, SA, Australia. Symonds EL; Cancer Research, Flinders Health and Medical Research Institute, Flinders University, Bedford Park, SA, Australia.; Bowel Health Service, Gastroenterology Department, Flinders Medical Centre, SALHN, Bedford Park, SA, Australia.
Pokaż więcej
Źródło:
Biomarker insights [Biomark Insights] 2024 Feb 28; Vol. 19, pp. 11772719241232870. Date of Electronic Publication: 2024 Feb 28 (Print Publication: 2024).
Detection of methylated BCAT1 and IKZF1 after curative-intent treatment as a prognostic indicator for colorectal cancer recurrence.
Autorzy:
Pedersen SK; Flinders Health and Medical Research Institute, Flinders University, South Australia, Australia.; Clinical Genomics Inc, New Jersey, USA. Symonds EL; Flinders Health and Medical Research Institute, Flinders University, South Australia, Australia.; Bowel Health Service, Flinders Medical Centre, South Australia, Australia. Roy AC; Flinders Health and Medical Research Institute, Flinders University, South Australia, Australia.; Department of Medical Oncology, Flinders Medical Centre, South Australia, Australia. Cornthwaite KJ; Flinders Health and Medical Research Institute, Flinders University, South Australia, Australia. LaPointe LC; Clinical Genomics Inc, New Jersey, USA. YoungGP; Flinders Health and Medical Research Institute, Flinders University, South Australia, Australia.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 Jan; Vol. 12 (2), pp. 1319-1329. Date of Electronic Publication: 2022 Jul 13.
Detection of hypermethylated BCAT1 and IKZF1 DNA in blood and tissues of colorectal, breast and prostate cancer patients.
Autorzy:
Winter JM; Cancer Research, Flinders Health and Medical Research Institute, College of Medicine and Public Health, Flinders University of South Australia, Bedford Park, South Australia, Australia.; Bowel Health Service, Flinders Medical Centre, Bedford Park, South Australia, Australia. Sheehan-Hennessy L; Cancer Research, Flinders Health and Medical Research Institute, College of Medicine and Public Health, Flinders University of South Australia, Bedford Park, South Australia, Australia.; Bowel Health Service, Flinders Medical Centre, Bedford Park, South Australia, Australia. Yao B; Cancer Research, Flinders Health and Medical Research Institute, College of Medicine and Public Health, Flinders University of South Australia, Bedford Park, South Australia, Australia. Pedersen SK; Clinical Genomics Pty Ltd, North Ryde, New South Wales, Australia. Wassie MM; Cancer Research, Flinders Health and Medical Research Institute, College of Medicine and Public Health, Flinders University of South Australia, Bedford Park, South Australia, Australia.; Bowel Health Service, Flinders Medical Centre, Bedford Park, South Australia, Australia. Eaton M; Flinders Breast Cancer Unit, Flinders Medical Centre, Bedford Park, South Australia, Australia. Chong M; Urology Services, Flinders Medical Centre, Bedford Park, South Australia, Australia. YoungGP; Cancer Research, Flinders Health and Medical Research Institute, College of Medicine and Public Health, Flinders University of South Australia, Bedford Park, South Australia, Australia. Symonds EL; Cancer Research, Flinders Health and Medical Research Institute, College of Medicine and Public Health, Flinders University of South Australia, Bedford Park, South Australia, Australia.; Bowel Health Service, Flinders Medical Centre, Bedford Park, South Australia, Australia.
Young-onset colorectal cancer is associated with a personal history of type 2 diabetes.
Autorzy:
Mikaeel RR; Department of Haematology and Oncology, The Queen Elizabeth Hospital, Woodville South, South Australia, Australia.; SAHMRI Colorectal Node, Basil Hetzel Institute, Woodville South, South Australia, Australia.; Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, South Australia, Australia.; Biology Department, College of Science, University of Duhok, Duhok, Kurdistan, Iraq. Symonds EL; Bowel Health Service, Flinders Medical Centre, Bedford Park, South Australia, Australia.; Flinders Centre for Innovation in Cancer, Flinders University, Bedford Park, South Australia, Australia. Kimber J; Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, South Australia, Australia. Smith E; Department of Haematology and Oncology, The Queen Elizabeth Hospital, Woodville South, South Australia, Australia.; University of Adelaide Department of Surgery, The Queen Elizabeth Hospital, Woodville South, South Australia, Australia. Horsnell M; Department of Haematology and Oncology, The Queen Elizabeth Hospital, Woodville South, South Australia, Australia. Uylaki W; Department of Haematology and Oncology, The Queen Elizabeth Hospital, Woodville South, South Australia, Australia.; Department of Gastroenterology, The Queen Elizabeth Hospital, Woodville South, South Australia, Australia. Tapia Rico G; Department of Medical Oncology, Royal Adelaide Hospital, Adelaide, Australia. Hewett PJ; University of Adelaide Department of Surgery, The Queen Elizabeth Hospital, Woodville South, South Australia, Australia. Yong J; University of Adelaide Department of Surgery, The Queen Elizabeth Hospital, Woodville South, South Australia, Australia. Tonkin D; University of Adelaide Department of Surgery, The Queen Elizabeth Hospital, Woodville South, South Australia, Australia. Jesudason D; Department of Endocrinology, The Queen Elizabeth Hospital, Woodville South, South Australia, Australia. Poplawski NK; Adult Genetics Unit, Royal Adelaide Hospital, Adelaide, South Australia, Australia.; Discipline of Paediatrics, Adelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, South Australia, Australia. Ruszkiewicz AR; Division of Anatomical Pathology, SA Pathology, Adelaide, South Australia, Australia.; Centre for Cancer Biology, University of South Australia, Adelaide, South Australia, Australia. Drew PA; University of Adelaide Department of Surgery, The Queen Elizabeth Hospital, Woodville South, South Australia, Australia. Hardingham JE; Department of Haematology and Oncology, The Queen Elizabeth Hospital, Woodville South, South Australia, Australia.; SAHMRI Colorectal Node, Basil Hetzel Institute, Woodville South, South Australia, Australia.; Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, South Australia, Australia. Wong S; Department of Gastroenterology and Hepatology, Royal Adelaide Hospital, Adelaide, Australia. Frank O; Discipline of General Practice, Adelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, South Australia, Australia. Tomita Y; Department of Haematology and Oncology, The Queen Elizabeth Hospital, Woodville South, South Australia, Australia. Patel D; Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, South Australia, Australia.; Department of Medical Oncology, Lyell McEwin Hospital, Elizabeth Vale, South Australia, Australia. Vatandoust S; Flinders Medical Centre, Bedford Park, South Australia, Australia. Townsend AR; Department of Haematology and Oncology, The Queen Elizabeth Hospital, Woodville South, South Australia, Australia. Roder D; Cancer Epidemiology and Population Health, University of South Australia, Adelaide, South Australia, Australia. YoungGP; Flinders Centre for Innovation in Cancer, Flinders University, Bedford Park, South Australia, Australia. Parry S; New Zealand Familial GI Cancer Service, Auckland City Hospital, Auckland, New Zealand.; National Bowel Screening Programme, Ministry of Health, New Zealand. Tomlinson IP; Institute of Cancer and Genomic Sciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom. Wittert G; Discipline of Medicine, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, South Australia, Australia. Wattchow D; Flinders University, Flinders Medical Centre, Bedford Park, South Australia, Australia. Worthley DL; South Australian Health & Medical Research Institute & School of Medicine, The University of Adelaide, Adelaide, South Australia, Australia. Brooks WJ; Adelaide Medical Solutions, Adelaide Health Solutions, Woodville, South Australia, Australia. Price TJ; Department of Haematology and Oncology, The Queen Elizabeth Hospital, Woodville South, South Australia, Australia.; Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, South Australia, Australia. Young JP; Department of Haematology and Oncology, The Queen Elizabeth Hospital, Woodville South, South Australia, Australia.; SAHMRI Colorectal Node, Basil Hetzel Institute, Woodville South, South Australia, Australia.; Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, South Australia, Australia.
Evaluation of a panel of tumor-specific differentially-methylated DNA regions in IRF4, IKZF1 and BCAT1 for blood-based detection of colorectal cancer.
Autorzy:
YoungGP; Flinders Health and Medical Research Institute, Flinders University, Adelaide, Australia. Symonds EL; Flinders Health and Medical Research Institute, Flinders University, Adelaide, Australia.; Bowel Health Service, Flinders Medical Centre, Bedford Park, South Australia, Australia. Nielsen HJ; Department of Surgical Gastroenterology, Hvidovre Hospital, University of Copenhagen, Hvidovre, Denmark. Ferm L; Department of Surgical Gastroenterology, Hvidovre Hospital, University of Copenhagen, Hvidovre, Denmark. Christensen IJ; Department of Surgical Gastroenterology, Hvidovre Hospital, University of Copenhagen, Hvidovre, Denmark. Dekker E; Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, Amsterdam, The Netherlands. van der Vlugt M; Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, Amsterdam, The Netherlands. Mallant-Hent RC; Department of Gastroenterology, Flevo Hospital, Almere, The Netherlands. Boulter N; Clinical Genomics Pty Ltd, North Ryde, NSW, Australia. Yu B; Clinical Genomics Pty Ltd, North Ryde, NSW, Australia. Chan M; Clinical Genomics Pty Ltd, North Ryde, NSW, Australia. Tevz G; Clinical Genomics Pty Ltd, North Ryde, NSW, Australia. LaPointe LC; Clinical Genomics Technologies Ltd, Edison, USA. Pedersen SK; Clinical Genomics Pty Ltd, North Ryde, NSW, Australia. .
Pokaż więcej
Źródło:
Clinical epigenetics [Clin Epigenetics] 2021 Jan 21; Vol. 13 (1), pp. 14. Date of Electronic Publication: 2021 Jan 21.
Effects of Dietary Fibre from the Traditional Indonesian Food, Green Cincau ( Premna oblongifolia Merr.) on Preneoplastic Lesions and Short Chain Fatty Acid Production in an Azoxymethane Rat Model of Colon Cancer.
Autorzy:
Nurdin SU; College of Science and Engineering, Flinders University, GPO Box 2100, Adelaide 5001, Australia. . Le Leu RK; Flinders Centre for Innovation in Cancer, Flinders University, GPO Box 2100, Adelaide 5001, Australia. . Aburto-Medina A; School of Science, RMIT University, P.O. Box 71, Bundoora, Victoria 3083, Australia. . YoungGP; Flinders Centre for Innovation in Cancer, Flinders University, GPO Box 2100, Adelaide 5001, Australia. graeme.young@flinders.edu.au. Stangoulis JCR; College of Science and Engineering, Flinders University, GPO Box 2100, Adelaide 5001, Australia. . Ball AS; School of Science, RMIT University, P.O. Box 71, Bundoora, Victoria 3083, Australia. . Abbott CA; College of Science and Engineering, Flinders University, GPO Box 2100, Adelaide 5001, Australia. .; Flinders Centre for Innovation in Cancer, Flinders University, GPO Box 2100, Adelaide 5001, Australia. .
Circulating tumour DNA for monitoring colorectal cancer-a prospective cohort study to assess relationship to tissue methylation, cancer characteristics and surgical resection.
Autorzy:
Symonds EL; 1Flinders Centre for Innovation in Cancer, College of Medicine and Public Health, Flinders University of South Australia, Bedford Park, South Australia 5042 Australia.; 2Bowel Health Service, Flinders Medical Centre, Bedford Park, South Australia Australia. Pedersen SK; Clinical Genomics Pty Ltd, North Ryde, New South Wales Australia. Murray DH; Clinical Genomics Pty Ltd, North Ryde, New South Wales Australia. Jedi M; 1Flinders Centre for Innovation in Cancer, College of Medicine and Public Health, Flinders University of South Australia, Bedford Park, South Australia 5042 Australia. Byrne SE; 1Flinders Centre for Innovation in Cancer, College of Medicine and Public Health, Flinders University of South Australia, Bedford Park, South Australia 5042 Australia. Rabbitt P; 4Colorectal Surgery, Division of Surgery and Perioperative Medicine, Flinders Medical Centre, Bedford Park, South Australia Australia. Baker RT; Clinical Genomics Pty Ltd, North Ryde, New South Wales Australia. Bastin D; 1Flinders Centre for Innovation in Cancer, College of Medicine and Public Health, Flinders University of South Australia, Bedford Park, South Australia 5042 Australia. YoungGP; 1Flinders Centre for Innovation in Cancer, College of Medicine and Public Health, Flinders University of South Australia, Bedford Park, South Australia 5042 Australia.
Pokaż więcej
Źródło:
Clinical epigenetics [Clin Epigenetics] 2018 May 16; Vol. 10, pp. 63. Date of Electronic Publication: 2018 May 16 (Print Publication: 2018).
Typ publikacji:
Clinical Trial; Journal Article; Observational Study; Research Support, Non-U.S. Gov't
Methylation and Gene Expression of BCAT1 and IKZF1 in Colorectal Cancer Tissues.
Autorzy:
Jedi M; Biotechnology, College of Medicine and Public Health, Flinders University, Bedford Park, SA, Australia. YoungGP; Flinders Centre for Innovation in Cancer, Flinders University, Bedford Park, SA, Australia. Pedersen SK; Clinical Genomics Pty Ltd, North Ryde, NSW, Australia. Symonds EL; Flinders Centre for Innovation in Cancer, Flinders University, Bedford Park, SA, Australia.; Bowel Health Service, Flinders Medical Centre, Bedford Park, SA, Australia.
Pokaż więcej
Źródło:
Clinical Medicine Insights. Oncology [Clin Med Insights Oncol] 2018 May 10; Vol. 12, pp. 1179554918775064. Date of Electronic Publication: 2018 May 10 (Print Publication: 2018).
Patterns of participation over four rounds of annual fecal immunochemical test-based screening for colorectal cancer: what predicts rescreening?
Autorzy:
Osborne JM; Bowel Health Service and Flinders Centre for Innovation in Cancer, Adelaide, Australia.; Flinders Centre for Innovation in Cancer, Flinders University of South Australia, GPO Box 2100, Adelaide, SA, 5001, Australia. Wilson C; Flinders Centre for Innovation in Cancer, Flinders University of South Australia, GPO Box 2100, Adelaide, SA, 5001, Australia. .; Olivia Newton John Cancer, Wellness and Research Centre, Heidelberg, Victoria, 3084, Australia. .; School of Psychology and Public Health, La Trobe University, Bundoora, Victoria, 3086, Australia. . Duncan A; Flinders Centre for Innovation in Cancer, Flinders University of South Australia, GPO Box 2100, Adelaide, SA, 5001, Australia. Cole SR; Bowel Health Service and Flinders Centre for Innovation in Cancer, Adelaide, Australia.; Flinders Centre for Innovation in Cancer, Flinders University of South Australia, GPO Box 2100, Adelaide, SA, 5001, Australia. Flight I; Flinders Centre for Innovation in Cancer, Flinders University of South Australia, GPO Box 2100, Adelaide, SA, 5001, Australia.; Olivia Newton John Cancer, Wellness and Research Centre, Heidelberg, Victoria, 3084, Australia. Turnbull D; University of Adelaide, North Terrace, Adelaide, SA, 5005, Australia. Hughes DL; Flinders Centre for Innovation in Cancer, Flinders University of South Australia, GPO Box 2100, Adelaide, SA, 5001, Australia.; Olivia Newton John Cancer, Wellness and Research Centre, Heidelberg, Victoria, 3084, Australia. YoungGP; Flinders Centre for Innovation in Cancer, Flinders University of South Australia, GPO Box 2100, Adelaide, SA, 5001, Australia.
Pokaż więcej
Źródło:
BMC public health [BMC Public Health] 2017 Aug 01; Vol. 18 (1), pp. 81. Date of Electronic Publication: 2017 Aug 01.
Findings in young adults at colonoscopy from a hospital service database audit.
Autorzy:
Wong S; Department of Gastroenterology, The Queen Elizabeth Hospital, Woodville South 5011, Adelaide, South Australia, Australia. Lidums I; Department of Gastroenterology, The Queen Elizabeth Hospital, Woodville South 5011, Adelaide, South Australia, Australia. Rosty C; Envoi Specialist Pathologists, Kelvin Grove 4059, Brisbane, QLD, Australia.; School of Medicine, University of Queensland, Herston 4006, Brisbane, QLD, Australia.; Department of Pathology, Colorectal Oncogenomics Group, Genetic Epidemiology Laboratory, The University of Melbourne, Parkville 3010, Melbourne, VIC, Australia. Ruszkiewicz A; Division of Anatomical Pathology, SA Pathology, Adelaide, 5000, South Australia, Australia.; Centre for Cancer Biology, University of South Australia, Adelaide, 5000, South Australia, Australia. Parry S; Familial GI Cancer Service and Ministry of Health Bowel Cancer Programme, Auckland City Hospital, Auckland, New Zealand. Win AK; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Parkville 3010, Melbourne, VIC, Australia. Tomita Y; Department of Haematology and Oncology, The Queen Elizabeth Hospital, Woodville South 5011, Adelaide, South Australia, Australia. Vatandoust S; Flinders Medical Centre, Bedford Park 5042, Adelaide, South Australia, Australia. Townsend A; Department of Haematology and Oncology, The Queen Elizabeth Hospital, Woodville South 5011, Adelaide, South Australia, Australia. Patel D; Flinders Medical Centre, Bedford Park 5042, Adelaide, South Australia, Australia. Hardingham JE; Department of Haematology and Oncology, The Queen Elizabeth Hospital, Woodville South 5011, Adelaide, South Australia, Australia.; School of Medicine, University of Adelaide, Adelaide, 5000, South Australia, Australia. Roder D; Cancer Epidemiology and Population Health, University of South Australia, Adelaide, 5000, South Australia, Australia. Smith E; Department of Haematology and Oncology, The Queen Elizabeth Hospital, Woodville South 5011, Adelaide, South Australia, Australia.; School of Medicine, University of Adelaide, Adelaide, 5000, South Australia, Australia. Drew P; School of Nursing and Midwifery, Flinders University, Bedford Park 5042, Adelaide, South Australia, Australia.; Basil Hetzel Institute, The Queen Elizabeth Hospital, Woodville South 5011, Adelaide, South Australia, Australia. Marker J; Cancer Voices SA, Kensington Park 5068, Adelaide, South Australia, Australia. Uylaki W; Department of Gastroenterology, The Queen Elizabeth Hospital, Woodville South 5011, Adelaide, South Australia, Australia.; Department of Haematology and Oncology, The Queen Elizabeth Hospital, Woodville South 5011, Adelaide, South Australia, Australia. Hewett P; University of Adelaide Department of Surgery, The Queen Elizabeth Hospital, Woodville South 5011, Adelaide, South Australia, Australia. Worthley DL; School of Medicine, University of Adelaide, Adelaide, 5000, South Australia, Australia.; Cancer Theme, South Australian Health and Medical Research Institute, Adelaide, 5000, South Australia, Australia. Symonds E; Flinders Centre for Innovation in Cancer, Flinders University, Bedford Park 5042, Adelaide, South Australia, Australia.; Bowel Health Service, Repatriation General Hospital, Daw Park 5041, Adelaide, South Australia, Australia. YoungGP; Flinders Centre for Innovation in Cancer, Flinders University, Bedford Park 5042, Adelaide, South Australia, Australia. Price TJ; Department of Haematology and Oncology, The Queen Elizabeth Hospital, Woodville South 5011, Adelaide, South Australia, Australia.; School of Medicine, University of Adelaide, Adelaide, 5000, South Australia, Australia. Young JP; Department of Haematology and Oncology, The Queen Elizabeth Hospital, Woodville South 5011, Adelaide, South Australia, Australia. joanne.young@adelaide.edu.au.; School of Medicine, University of Adelaide, Adelaide, 5000, South Australia, Australia. joanne.young@adelaide.edu.au.; SAHMRI Colorectal Node, Basil Hetzel Institute, Woodville South, Adelaide, South Australia, 5011, Australia. joanne.young@adelaide.edu.au.
Pokaż więcej
Źródło:
BMC gastroenterology [BMC Gastroenterol] 2017 Apr 19; Vol. 17 (1), pp. 56. Date of Electronic Publication: 2017 Apr 19.
A cross-sectional study comparing a blood test for methylated BCAT1 and IKZF1 tumor-derived DNA with CEA for detection of recurrent colorectal cancer.
Autorzy:
YoungGP; Flinders Centre for Innovation in Cancer, Flinders University of South Australia, Bedford Park, South Australia, Australia. graeme.young@flinders.edu.au. Pedersen SK; Clinical Genomics Pty Ltd, North Ryde, New South Wales, Australia. Mansfield S; Colorectal Surgery, Division of Surgery & Perioperative Medicine, Flinders Medical Centre, Bedford Park, South Australia, Australia. Murray DH; Clinical Genomics Pty Ltd, North Ryde, New South Wales, Australia. Baker RT; Clinical Genomics Pty Ltd, North Ryde, New South Wales, Australia. Rabbitt P; Colorectal Surgery, Division of Surgery & Perioperative Medicine, Flinders Medical Centre, Bedford Park, South Australia, Australia. Byrne S; Flinders Centre for Innovation in Cancer, Flinders University of South Australia, Bedford Park, South Australia, Australia. Bambacas L; Flinders Centre for Innovation in Cancer, Flinders University of South Australia, Bedford Park, South Australia, Australia. Hollington P; Colorectal Surgery, Division of Surgery & Perioperative Medicine, Flinders Medical Centre, Bedford Park, South Australia, Australia. Symonds EL; Flinders Centre for Innovation in Cancer, Flinders University of South Australia, Bedford Park, South Australia, Australia.; Bowel Health Service, Repatriation General Hospital, Daw Park, South Australia, Australia.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2016 Oct; Vol. 5 (10), pp. 2763-2772. Date of Electronic Publication: 2016 Oct 11.
Typ publikacji:
Comparative Study; Journal Article; Observational Study; Research Support, Non-U.S. Gov't
Sociodemographic disparities in survival from colorectal cancer in South Australia: a population-wide data linkage study.
Autorzy:
Beckmann KR; Centre for Population Health Research, University of South Australia, GPO Box 2471, Adelaide, SA, 5001, Australia. . Bennett A; Flinders Medical Centre, Flinders Drive, Bedford Park, SA, 5042, Australia. YoungGP; Flinders Centre for Innovation in Cancer, Flinders University, Flinders Drive, Bedford Park, SA, 5042, Australia. Cole SR; Flinders Centre for Innovation in Cancer, Flinders University, Flinders Drive, Bedford Park, SA, 5042, Australia. Joshi R; Lyell McEwin Hospital, Elizabeth Vale, SA, 5112, Australia. Adams J; Country Health SA, Adelaide, SA, 5000, Australia.; Lyell McEwin Hospital, Elizabeth Vale, SA, 5112, Australia. Singhal N; Medical Oncologist, Royal Adelaide Hospital, University of Adelaide, Adelaide, SA, 5001, Australia. Karapetis C; Flinders Centre for Innovation in Cancer, Flinders University, Flinders Drive, Bedford Park, SA, 5042, Australia.; South Adelaide Health Network, Medical Oncology, Flinders Medical Centre, Flinders Drive, Bedford Park, SA, 5042, Australia. Wattchow D; Flinders University, Flinders Medical Centre, Bedford Park, SA, 5042, Australia. Roder D; Centre for Population Health Research, University of South Australia, GPO Box 2471, Adelaide, SA, 5001, Australia.
Pokaż więcej
Źródło:
BMC health services research [BMC Health Serv Res] 2016 Jan 20; Vol. 16, pp. 24. Date of Electronic Publication: 2016 Jan 20.
Evaluation of an assay for methylated BCAT1 and IKZF1 in plasma for detection of colorectal neoplasia.
Autorzy:
Pedersen SK; Clinical Genomics Pty Ltd, Sydney, Australia. . Symonds EL; Flinders Centre for Innovation in Cancer, Flinders University of South Australia, Adelaide, Australia. .; Bowel Health Service, Repatriation General Hospital, Adelaide, Australia. . Baker RT; Clinical Genomics Pty Ltd, Sydney, Australia. . Murray DH; Clinical Genomics Pty Ltd, Sydney, Australia. . McEvoy A; Clinical Genomics Pty Ltd, Sydney, Australia. . Van Doorn SC; Academic Medical Centre, Amsterdam, The Netherlands. . Mundt MW; Flevo Hospital, Almere, The Netherlands. . Cole SR; Flinders Centre for Innovation in Cancer, Flinders University of South Australia, Adelaide, Australia. .; Bowel Health Service, Repatriation General Hospital, Adelaide, Australia. . Gopalsamy G; Flinders Centre for Innovation in Cancer, Flinders University of South Australia, Adelaide, Australia. . Mangira D; Flinders Centre for Innovation in Cancer, Flinders University of South Australia, Adelaide, Australia. . LaPointe LC; Clinical Genomics Pty Ltd, Sydney, Australia. . Dekker E; Academic Medical Centre, Amsterdam, The Netherlands. . YoungGP; Flinders Centre for Innovation in Cancer, Flinders University of South Australia, Adelaide, Australia. graeme.young@flinders.edu.au.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2015 Oct 06; Vol. 15, pp. 654. Date of Electronic Publication: 2015 Oct 06.
Typ publikacji:
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
